NIH Guide: Weekly Index for September 16, 2022

Funding Opportunities

• Agency for Healthcare Research and Quality (AHRQ)-sponsored National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)
  (PA-22-251)
  Agency for Healthcare Research and Quality
  Application Receipt Date(s): Standard dates apply AHRQ F32: April 8, August 8, and December 8, annually. All applications are due, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)
  (PAR-22-129)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): January 9, 2025
• NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)
  (PAR-22-225)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): May 7, 2026
• Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 - Clinical Trial Optional)
  (PAR-22-250)
  National Institute of General Medical Sciences
  Application Receipt Date(s): January 30, 2025
• Limited Competition: IDeA Regional Entrepreneurship Development (I-RED) Program (STTR) (UT2 Clinical Trial Not Allowed)
  (PAR-22-254)
  National Institute of General Medical Sciences
  Application Receipt Date(s): January 06, 2023
• NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)
  (RFA-CA-22-035)
  National Cancer Institute
  Application Receipt Date(s): February 28, 2023
• NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)
  (RFA-CA-22-036)
  National Cancer Institute
  Application Receipt Date(s): February 28, 2023
• NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required)
  (RFA-CA-22-037)
  National Cancer Institute
  Application Receipt Date(s): February 28, 2023
• Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Centers (U54 Clinical Trial Not Allowed)
  (RFA-CA-22-055)
  National Cancer Institute
  Application Receipt Date(s): November 21, 2022
• Limited Competition: The NHGRI Genomic Data Science Analysis, Visualization, and Informatics Lab-space (AnVIL) (U24 Clinical Trial Not Allowed)
  (RFA-HG-22-020)
  National Human Genome Research Institute
  Application Receipt Date(s): Not Applicable
• The NHGRI Genomic Data Science Analysis, Visualization, and Informatics Lab-space Clinical Resource (ACR) (U24 Clinical Trial Not Allowed)
  (RFA-HG-22-021)
  National Human Genome Research Institute
  Application Receipt Date(s): Not Applicable
• HEAL Initiative: Prevention and Management of Chronic Pain in Rural Populations (UG3/UH3, Clinical Trials Required)
  (RFA-NR-23-001)
  National Institute of Nursing Research
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Heart, Lung, and Blood Institute
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  Office of Disease Prevention
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): November 21, 2022
• HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 Clinical Trial Not Allowed)
  (RFA-NS-23-006)
  National Institute of Neurological Disorders and Stroke
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of General Medical Sciences
  National Institute of Dental and Craniofacial Research
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Heart, Lung, and Blood Institute
  National Institute of Mental Health
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Center for Advancing Translational Sciences
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): Multiple dates, see announcement.
• HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)
  (RFA-NS-23-007)
  National Institute of Neurological Disorders and Stroke
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of General Medical Sciences
  National Cancer Institute
  National Institute of Dental and Craniofacial Research
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Heart, Lung, and Blood Institute
  National Institute of Mental Health
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Center for Advancing Translational Sciences
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): Multiple dates, see announcement.